{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T21:30:19Z","timestamp":1764192619046,"version":"3.40.5"},"reference-count":30,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDS"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Toxic Epidermal Necrolysis (TEN) is a rare, acute, and life-threatening\nmucocutaneous disease that occurs after the administration of certain drugs, resulting in extensive\nkeratinocyte cell death, skin involvement at the dermal-epidermal junction, and extensive bullous\nskin eruptions and sloughing. Many published case reports have observed the presence of fever\nwith a viral infection, drug, and\/or genetic association as a possible trigger for TEN but associated\nwith other comorbidities. Physicians still struggle to predict which individuals could be predisposed\nto TEN. The case report that we present had a history of multiple drug intake and fever due\nto dengue virus infection but was not associated with any other comorbidity.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Case Presentation:<\/jats:title>\n<jats:p>We present an unusual case of a 32-year-old woman of Western Indian origin\nwho had developed dengue infection and suffered toxic epidermal necrolysis following a five-day\ncourse of a third-generation cephalosporin antibiotic, cefixime and a three-day course of 2 analgesic\ndrugs, paracetamol (acetaminophen), and nimesulide, with the adverse event occurring on the\nfifth day of the dengue infection. The offending drugs were stopped, and patient survived with\nsupportive management and hydration.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The presence of comorbidities may not always be the triggering factor for TEN,\nthough it can affect patient outcomes. Rational drug use is always recommended for patient care.\nFurther research is required to understand the pathomechanism behind the viral-drug-gene interaction.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574886318666230418104445","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T03:21:09Z","timestamp":1681960869000},"page":"286-290","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Case Report of Cefixime, Paracetamol, and Nimesulide Induced Toxic\nEpidermal Necrolysis in a Woman with Dengue Infection without any\nOther Associated Comorbidities"],"prefix":"10.2174","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9637-6891","authenticated-orcid":true,"given":"Renuka","family":"Munshi","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology, Topiwala National Medical College &amp; Bai Yamunabai Laxman Nair Charitable\nHospital, Mumbai, 400008, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6328-4731","authenticated-orcid":true,"given":"Miteshkumar","family":"Maurya","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Topiwala National Medical College &amp; Bai Yamunabai Laxman Nair Charitable\nHospital, Mumbai, 400008, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1365-2133.1956.tb12766.x","volume":"68","author":"Lyell A.","year":"1956","unstructured":"Lyell A.; Toxic epidermal necrolysis: An eruption resembling scalding of the skin. Br J Dermatol 1956,68(11),355-361","journal-title":"Br J Dermatol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/S0140-6736(98)05418-X","volume":"353","author":"Rzany B.","year":"1999","unstructured":"Rzany B.; Correia O.; Kelly J.P.; Naldi L.; Auquier A.; Stern R.; Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: A case-control study. Lancet 1999,353(9171),2190-2194","journal-title":"Lancet"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2165\/00002018-200528100-00008","volume":"28","author":"La Grenade L.","year":"2005","unstructured":"La Grenade L.; Lee L.; Weaver J.; Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors. Drug Saf 2005,28(10),917-924","journal-title":"Drug Saf"},{"key":"ref=4","first-page":"97","volume":"26","author":"Achten G.","year":"1970","unstructured":"Achten G.; Ledoux-Corbusier M.; Toxic epidermal necrolysis de Lyell: Aspects histologiques. Arch Belg Dermatol Syphiligr 1970,26(2),97-114","journal-title":"Arch Belg Dermatol Syphiligr"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2332\/allergolint.55.9","volume":"55","author":"French L.E.","year":"2006","unstructured":"French L.E.; Toxic epidermal necrolysis and Stevens Johnson syndrome: Our current understanding. Allergol Int 2006,55(1),9-16","journal-title":"Allergol Int"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.4110\/in.2016.16.4.256","volume":"16","author":"Ban G.Y.","year":"2016","unstructured":"Ban G.Y.; Ahn S.J.; Yoo H.S.; Park H.S.; Ye Y.M.; Stevens\u2013Johnson syndrome and toxic epidermal necrolysis associated with acetaminophen use during viral infections. Immune Netw 2016,16(4),256-260","journal-title":"Immune Netw"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000322963","volume":"2","author":"Grieb G.","year":"2010","unstructured":"Grieb G.; Alazemi M.; Das R.; Dunda S.E.; Fuchs P.C.; Pallua N.; A rare case of toxic epidermal necrolysis with unexpected Fever resulting from dengue virus. Case Rep Dermatol 2010,2(3),189-194","journal-title":"Case Rep Dermatol"},{"key":"ref=8","first-page":"80","volume":"19","author":"Torres M.J.","year":"2009","unstructured":"Torres M.J.; Mayorga C.; Blanca M.; Nonimmediate allergic reactions induced by drugs: Pathogenesis and diagnostic tests. J Investig Allergol Clin Immunol 2009,19(2),80-90","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/1346-8138.12674","volume":"42","author":"Abe R.","year":"2015","unstructured":"Abe R.; Immunological response in Stevens-Johnson syndrome and toxic epidermal necrolysis. J Dermatol 2015,42(1),42-48","journal-title":"J Dermatol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","volume":"115","author":"Fouchard N.","year":"2000","unstructured":"Fouchard N.; Bertocchi M.; Roujeau J-C.; Revuz J.; Wolkenstein P.; Bastuji-Garin S.; SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 2000,115(2),149-153","journal-title":"J Invest Dermatol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/clpt.2009.252","volume":"88","author":"Sassolas B.","year":"2010","unstructured":"Sassolas B.; Haddad C.; Mockenhaupt M.; ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther 2010,88(1),60-68","journal-title":"Clin Pharmacol Ther"},{"key":"ref=12","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.108651","author":"Rajaram Maurya M.","year":"2023","unstructured":"Rajaram Maurya M.; Munshi R.; Bhausaheb Zambare S.; Thakur S.; Perspective chapter: Drug-induced severe cutaneous Adverse Reactions, diagnostics and management. Immunosuppression and Immunomodulation 2023","journal-title":"Immunosuppression and Immunomodulation"},{"key":"ref=13","first-page":"319","author":"French L.E.","year":"2013","unstructured":"French L.E.; Prins C.; Prins C: Erythema multiforme, stevens-johnson syndrome and toxic epidermal necrolysis. Dermatology 2013,319-333","journal-title":"Dermatology"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/00185787211016332","volume":"57","author":"Babu T.","year":"2022","unstructured":"Babu T.; Panachiyil G.M.; Vasudev P.H.; Ravi M.D.; A rare pediatric case of cefixime induced toxic epidermal necrolysis. Hosp Pharm 2022,57(2),237-240","journal-title":"Hosp Pharm"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1001\/archderm.1991.01680050083008","volume":"127","author":"Sch\u00f6pf E.","year":"1991","unstructured":"Sch\u00f6pf E.; St\u00fchmer A.; Rzany B.; Victor N.; Zentgraf R.; Kapp J.F.; Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany. Arch Dermatol 1991,127(6),839-842","journal-title":"Arch Dermatol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"e359","DOI":"10.7759\/cureus.359","volume":"7","author":"Boroda K.","year":"2015","unstructured":"Boroda K.; Li L.; Riina L.; Ahmed S.; Cephalosporin-induced toxic epidermal necrolysis treated with intravenous immunoglobulin. Cureus 2015,7(10),e359","journal-title":"Cureus"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.0736-8046.2004.21309.x","volume":"21","author":"Bygum A.","year":"2004","unstructured":"Bygum A.; Gregersen J.W.; Buus S.K.; Acetaminophen-induced toxic epidermal necrolysis in a child. Pediatr Dermatol 2004,21(3),236-238","journal-title":"Pediatr Dermatol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1345\/aph.19064","volume":"34","author":"Halevi A.","year":"2000","unstructured":"Halevi A.; Ben-Amitai D.; Garty B.Z.; Toxic epidermal necrolysis associated with acetaminophen ingestion. Ann Pharmacother 2000,34(1),32-34","journal-title":"Ann Pharmacother"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.47992\/IJHSP.2581.6411.0019","volume":"1","author":"Dias E.","year":"2017","unstructured":"Dias E.; Rai V.; Three years old child with toxic epidermal necrolysis due to paracetamol tablet ingestion. Inter J Health Sci Pharma [IJHSP] 2017,1(2),68-71","journal-title":"Inter J Health Sci Pharma [IJHSP]"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"810","DOI":"10.18203\/2319-2003.ijbcp20201764","volume":"9","author":"Xaviar S.","year":"2020","unstructured":"Xaviar S.; Ravichandran M.; A case of nimesulide induced toxic epidermal necrolysis. Int J Basic Clin Pharmacol 2020,9(5),810-812","journal-title":"Int J Basic Clin Pharmacol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4103\/0022-3859.40786","volume":"54","author":"Chatterjee S.","year":"2008","unstructured":"Chatterjee S.; Pal J.; Biswas N.; Nimesulide-induced hepatitis and toxic epidermal necrolysis. J Postgrad Med 2008,54(2),150-151","journal-title":"J Postgrad Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.18203\/2319-2003.ijbcp20175223","volume":"6","author":"Kumar V.","year":"2017","unstructured":"Kumar V.; Nimesulide induced toxic epidermal necrolysis: A rare case report. Inter J Basic Clin Pharmacol 2017,6(12),2939-2942","journal-title":"Inter J Basic Clin Pharmacol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2174\/1574886310666150921103852","volume":"11","author":"Pena M.\u00c1.","year":"2016","unstructured":"Pena M.\u00c1.; P\u00e9rez S.; Zazo M.C.; A case of toxic epidermal necrolysis secondary to acetaminophen in a child. Curr Drug Saf 2016,11(1),99-101","journal-title":"Curr Drug Saf"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"831","DOI":"10.5455\/2319-2003.ijbcp20131232","volume":"2","author":"Gupta M.C.","year":"2017","unstructured":"Gupta M.C.; Mittal N.; Toxic epidermal necrolysis induced by acetaminophen: A case report. Inter J Basic Clin Pharmacol 2017,2(6),831-832","journal-title":"Inter J Basic Clin Pharmacol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/00004630-199920060-00012","volume":"20","author":"Sheridan R.L.","year":"1999","unstructured":"Sheridan R.L.; Weber J.M.; Schulz J.T.; Ryan C.M.; Low H.M.; Tompkins R.G.; Management of severe toxic epidermal necrolysis in children. J Burn Care Rehabil 1999,20(6),497-500","journal-title":"J Burn Care Rehabil"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/microorganisms9010202","volume":"9","author":"Lipovy B.","year":"2021","unstructured":"Lipovy B.; Holoubek J.; Hanslianova M.; Impact of antibiotics associated with the development of toxic epidermal necrolysis on early and late-onset infectious complications. Microorganisms 2021,9(1),202","journal-title":"Microorganisms"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1120009X.2022.2051128","volume":"2022","author":"Pejcic A.V.","year":"2022","unstructured":"Pejcic A.V.; Milosavljevic M.N.; Folic M.; Amoxicillin-associated Stevens-Johnson syndrome or toxic epidermal necrolysis: Systematic review. J Chemother 2022,2022,1-12","journal-title":"J Chemother"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.5415\/apallergy.2022.12.e17","volume":"12","author":"Yoo H.W.","year":"2022","unstructured":"Yoo H.W.; Kim H.Y.; Shin K.; Kim S.H.; Clinical characteristics of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A single-center study. Asia Pac Allergy 2022,12(2),e17","journal-title":"Asia Pac Allergy"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/09546634.2018.1509047","volume":"31","author":"Diao M.","year":"2020","unstructured":"Diao M.; Thapa C.; Ran X.; Ran Y.; Lv X.; A retrospective analysis of infections and antibiotic treatment in patients with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. J Dermatolog Treat 2020,31(1),61-65","journal-title":"J Dermatolog Treat"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3390\/medicina57090895","volume":"57","author":"Frantz R.","year":"2021","unstructured":"Frantz R.; Huang S.; Are A.; Motaparthi K.; Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: A review of diagnosis and management. Medicina 2021,57(9),895","journal-title":"Medicina"}],"container-title":["Current Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574886318666230418104445","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/215969\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574886318666230418104445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T12:21:00Z","timestamp":1702470060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/215969\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574886318666230418104445","relation":{},"ISSN":["1574-8863"],"issn-type":[{"type":"print","value":"1574-8863"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-11-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}